Letters Judging benefits and harms of medicines

Credibility and trust are required to judge the benefits and harms of medicines

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j4204 (Published 20 September 2017) Cite this as: BMJ 2017;358:j4204
  1. David B Menkes, academic psychiatrist1,
  2. Dick Bijl, physician-epidemiologist and president, International Society of Drug Bulletins2
  1. 1Waikato Clinical Campus, University of Auckland, Hamilton 3240, New Zealand
  2. 2Vredenburgplein 40, 3511 WH Utrecht, the Netherlands
  1. david.menkes{at}auckland.ac.nz

Freer and Godlee consider the serious doubts held by both the public and the profession regarding drug efficacy and safety, and they lament the weak recommendations made by the Academy of Medical Sciences to tackle the fundamental problem of conflicts of interest in drug information.12

Medical journals have a key role in accessing clinical trial and other evidence on drugs, …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe